» Articles » PMID: 28844237

Genotoxicity Testing: Comparison of the γH2AX Focus Assay with the Alkaline and Neutral Comet Assays

Overview
Publisher Elsevier
Date 2017 Aug 29
PMID 28844237
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Genotoxicity testing relies on the quantitative measurement of adverse effects, such as chromosome aberrations, micronuclei, and mutations, resulting from primary DNA damage. Ideally, assays will detect DNA damage and cellular responses with high sensitivity, reliability, and throughput. Several novel genotoxicity assays may fulfill these requirements, including the comet assay and the more recently developed γH2AX assay. Although they are thought to be specific for genotoxicants, a systematic comparison of the assays has not yet been undertaken. In the present study, we compare the γH2AX focus assay with the alkaline and neutral versions of the comet assay, as to their sensitivities and limitations for detection of genetic damage. We investigated the dose-response relationships of γH2AX foci and comet tail intensities at various times following treatment with four prototypical genotoxicants, methyl methanesulfonate (MMS), N-methyl-N'-nitro-N-nitrosoguanidine (MNNG), mitomycin C, and hydrogen peroxide (HO) and we tested whether there is a correlation between the endpoints, i.e., alkali-labile sites and DNA strand breaks on the one hand and the cell's response to DNA double-strand breaks and blocked replication forks on the other. Induction of γH2AX foci gave a linear dose response and all agents tested were positive in the assay. The increase in comet tail intensity was also a function of dose; however, mitomycin C was almost completely ineffective in the comet assay, and the doses needed to achieve a significant effect were somewhat higher for some treatments in the comet assay than in the γH2AX foci assay, which was confirmed by threshold analysis. There was high correlation between tail intensity and γH2AX foci for MMS and HO, less for MNNG, and none for mitomycin C. From this we infer that the γH2AX foci assay is more reliable, sensitive, and robust than the comet assay for detecting genotoxicant-induced DNA damage.

Citing Articles

DNA damage response in breast cancer and its significant role in guiding novel precise therapies.

Li J, Jia Z, Dong L, Cao H, Huang Y, Xu H Biomark Res. 2024; 12(1):111.

PMID: 39334297 PMC: 11437670. DOI: 10.1186/s40364-024-00653-2.


Analysis of Single- and Double-Stranded DNA Damage in Osteoblastic Cells after Hyperbaric Oxygen Exposure.

Schonrock N, Tillmans F, Sebens S, Kahler W, Klapa S, Rieger B Antioxidants (Basel). 2023; 12(4).

PMID: 37107226 PMC: 10135236. DOI: 10.3390/antiox12040851.


Genotoxicity of Novel Pyrazolo[4,3-]tetrazolo[1,5-][1,2,4]triazine Sulfonamides in Normal and Cancer Cells In Vitro.

Kciuk M, Mujwar S, Marciniak B, Gielecinska A, Bukowski K, Mojzych M Int J Mol Sci. 2023; 24(4).

PMID: 36835469 PMC: 9966268. DOI: 10.3390/ijms24044053.


Class I HDAC overexpression promotes temozolomide resistance in glioma cells by regulating RAD18 expression.

Hanisch D, Krumm A, Diehl T, Stork C, Dejung M, Butter F Cell Death Dis. 2022; 13(4):293.

PMID: 35365623 PMC: 8975953. DOI: 10.1038/s41419-022-04751-7.


Cytotoxic, Genotoxic and Senolytic Potential of Native and Micellar Curcumin.

Beltzig L, Frumkina A, Schwarzenbach C, Kaina B Nutrients. 2021; 13(7).

PMID: 34371895 PMC: 8308652. DOI: 10.3390/nu13072385.